Elizabeth Fabre
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 21
- Lung Cancer Research Studies 13
- Colorectal Cancer Treatments and Studies 10
- Pancreatic and Hepatic Oncology Research 6
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 14
-
- Lung Cancer Treatments and Mutations 37
- Lung Cancer Diagnosis and Treatment 18
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Pathology and Forensic Medicine top 10%
- Co-authors
- Hélène BlonsPierre Laurent‐PuigFrançoise Le Pimpec‐BarthesNicolas PécuchetAudrey DidelotÉric TartourLaure GibaultValérie Taly
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Elizabeth Fabre
84 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Oncology 725
- Cancer Research 367
- Pulmonary and Respiratory Medicine 583
- Immunology 305
- Pathology and Forensic Medicine 153
Countries citing papers authored by Elizabeth Fabre
This map shows the geographic impact of Elizabeth Fabre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Fabre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Fabre more than expected).
Fields of papers citing papers by Elizabeth Fabre
This network shows the impact of papers produced by Elizabeth Fabre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Fabre. The network helps show where Elizabeth Fabre may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth Fabre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 18 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 10 | |
| 10 | 2019 | 67 | |
| 11 | 2019 | 4 | |
| 12 | 2016 | 75 | |
| 13 | 2016 | 5 | |
| 14 | 2016 | 0 | |
| 15 | 2016 | 2 | |
| 16 | 2014 | 1 | |
| 17 | 2012 | 76 | |
| 18 | 2012 | 12 | |
| 19 | Les cancers du rectum : mise au point | 2000 | 1 |
| 20 | Le cancer du côlon : mise au point | 2000 | 4 |
About Elizabeth Fabre
Elizabeth Fabre is a scholar working on Microbiology, Oncology and Pulmonary and Respiratory Medicine, having authored 91 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Diagnosis and Treatment (18 papers), Cancer Genomics and Diagnostics (14 papers), Lung Cancer Research Studies (13 papers), Colorectal Cancer Treatments and Studies (10 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Oncology (725 citations), Cancer Research (367 citations) and Pulmonary and Respiratory Medicine (583 citations). Elizabeth Fabre has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Hélène Blons, Pierre Laurent‐Puig, Françoise Le Pimpec‐Barthes, Nicolas Pécuchet, Audrey Didelot, Éric Tartour, Laure Gibault, Valérie Taly, Y. Pouliquen and Eleonora Zonta. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.